Rwanda vs Uruguay: Cause of death, by non-communicable diseases, ages 15-59, male
Rwanda
48.4%
in 2021
Uruguay
48.4%
in 2021
Rwanda rank
98th
Uruguay rank
97th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Rwanda
- Uruguay
How they compare
Uruguay currently reports 48.4% against 48.4% in Rwanda, a difference of 0.0%.
Across all 6 years both countries report, Uruguay has been ahead every year.
Rwanda ranks 98th and Uruguay ranks 97th of 185 countries.
Uruguay has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Rwanda | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.8% | 64.1% | 30.3% | Uruguay |
| 2010s | 44.5% | 59.8% | 15.3% | Uruguay |
| 2020s | 49.1% | 53.6% | 4.5% | Uruguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Rwanda or Uruguay?
- Uruguay, at 48.4% against 48.4% in Rwanda as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Rwanda and Uruguay?
- 0.0%, with Uruguay ahead.
- How many years of comparable data are there for Rwanda and Uruguay?
- 6 years are reported by both, from 2000 to 2021.
- How do Rwanda and Uruguay rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Rwanda ranks 98th and Uruguay ranks 97th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.